# Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis

> **NCT01887600** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Europe B.V.** · enrollment: 594 (actual)

## Conditions studied

- Anemia in Chronic Kidney Disease in Non-dialysis Patients

## Interventions

- **DRUG:** Roxadustat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01887600
- **Lead sponsor:** Astellas Pharma Europe B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-03
- **Primary completion:** 2017-11-01
- **Final completion:** 2017-11-01
- **Target enrollment:** 594 (ACTUAL)
- **Last updated:** 2024-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01887600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01887600, "Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01887600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*